Skip to Main Content

4,314

Views

7

CrossRef citations to date

0

Altmetric

Original Articles

Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study

Toby A. Eyrea Oxford Cancer and Hematology Centre, Oxford University NHS Foundation Trust, Oxford, UKCorrespondence[email protected]
View further author information

,

Lisa M. Hessb Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Tomoko Sugiharac Syneos Health, Inc, Morrisville, NC, USAView further author information

,

Dan Hec Syneos Health, Inc, Morrisville, NC, USAView further author information

,

Manoj Khanalb Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

John M. Pageld Loxo@Lilly, Indianapolis, IN, USAView further author information

,

Richard A. Walgrend Loxo@Lilly, Indianapolis, IN, USAView further author information

,

Paolo B. Abadad Loxo@Lilly, Indianapolis, IN, USAView further author information

,

Heiko Konigd Loxo@Lilly, Indianapolis, IN, USAView further author information

,

Lindsey E. Roekere Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information

&

Anthony Matoe Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information